Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-m8s7h Total loading time: 0 Render date: 2024-07-18T18:21:24.478Z Has data issue: false hasContentIssue false

Chapter 7 - Fertility Preservation in Non-Cancer Patients

from Section 3 - Fertility Preservation in Cancer and Non-Cancer Patients

Published online by Cambridge University Press:  27 March 2021

By
Javier Domingo ,
Ana Cobo  and
Antonio Pellicer
Edited by
Jacques Donnez  and
S. Samuel Kim
Jacques Donnez
Affiliation:
Catholic University of Louvain, Brussels
S. Samuel Kim
Affiliation:
University of Kansas School of Medicine
Get access

Summary

The increasing survival rates of cancer patients [1] have encouraged many specialists to focus on the irreversible consequences of chemotherapy and radiotherapy. Chemotherapy and radiotherapy treatment for cancer or other pathologies have resulted in improved survival rates, but these treatments may also lead to sterility [2]. The increasing success of oncological treatments means it is now even more crucial to implement procedures aimed at preserving fertility.

Similar to cancer patients, there are some non-oncological conditions currently treated with gonadotoxic agents, such as patients with autoimmune disorders or some chromosomal abnormalities that can lead to ovarian failure. There are also other situations where a woman may benefit from fertility preservation procedures, such as women with severe or recurrent endometriosis or women who electively postpone conception [3].

Type
Chapter
Information
Fertility Preservation
Principles and Practice
 , pp. 67 - 78
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Surveillance, Epidemiology and End Results Program, 1975–2015, Division of Cancer Control and Population Sciences, National Cancer Institute, 2018.Google Scholar
Larsen, EC, Müller, J, Schmiegelow, K et al. Reduced ovarian function in long-term survivors of radiation and chemotherapy-treated childhood cancer. J Clin Endocrinol Met, 2003;88:5307–5314.Google Scholar
Gidoni, Y, Holzer, H, Tulandi, T et al. Fertility preservation in patients with non-oncological conditions. Reprod Biomed Online, 2008;16:792–800.CrossRefGoogle ScholarPubMed
Cobo, A, Bellver, J, Domingo, J et al. New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online, 2008;17:68–72.Google Scholar
Meseguer, M, Molina, N, García-Velasco, JA et al. Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril, 2006;85:640–645.CrossRefGoogle ScholarPubMed
Kuwayama, M, Vajta, G, Kato, O et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online, 2005;11:300–308.Google Scholar
Silber, SJ, Derosa, M, Pineda, J et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod, 2008;23:1531–1537.Google Scholar
Elgindy, E, Sibai, H, Abdelghani, A et al. Protecting ovaries during chemotherapy through gonad suppression: A systematic review and metaanalysis. Obstet Gynecol, 2015;126:187–195.Google Scholar
De Vos, M, Smitz, J, Woodruff, T. Fertility preservation in women with cancer. Lancet, 2014;384:1302–1310.Google Scholar
Tulandi, T, Huang, JY, Tan, SL. Preservation of female fertility: an essential progress. Obstet Gynecol, 2008;112:1160–1172.Google Scholar
Bines, J, Oleske, DM, Cobleigh, MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol, 1996;14:1718–1729.Google Scholar
Poniatowski, BC, Grimm, P, Cohen, G. Chemotherapy-induced menopause: A literature review. Cancer Invest, 2001;19:641–648.Google Scholar
Meirow, D, Nugent, D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update, 2001;7:535–543.Google Scholar
Meirow, D, Epstein, M, Lewis, H et al. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod, 2001;16:632–637.Google Scholar
Martinez, F. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril, 2017;108:407–415.Google Scholar
Sonmezer, M, Oktay, K. Fertility preservation in young women undergoing breast cancer therapy. The Oncologist, 2006;11:422–434.CrossRefGoogle ScholarPubMed
Warne, GL, Fairley, KF, Hobbs, JB et al. Cyclophosphamide-induced ovarian failure. N Engl J Med, 1973;289:1159–1162.Google Scholar
Marcello, MF, Nuciforo, G, Romeo, R et al. Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer, 1990;66:2099–2104.Google Scholar
Familiari, G, Caggiati, A, Nottola, SA et al. Ultrastructure of human primordial follicles after combination chemotherapy for Hodgkin´s disease. Hum Reprod, 1993;8:2080–2087.Google Scholar
Meirow, D, Dor, J, Kaufman, B et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod, 2007;22:1626–1633.Google Scholar
Anderson, RA, Themmen, AP, Al-Qahtani, A et al. The effects of chemotherapy and long term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod, 2006;21:2583–2592.Google Scholar
Wallace, WH, Thomson, AB, Kelsey, TW. The radiosensitivity of human oocyte. Hum Reprod, 2003;18:117–121.Google Scholar
Howell, SJ, Shalet, S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin, 1998;27:927–943.Google Scholar
Patrick, K, Wallace, WH, Critchley, H. Late reproductive effects of cancer treatment in female survivors of childhood malignancy. Curr Obstet Gynecol, 2003;13:369–372.Google Scholar
Goynumer, G, Kayabasoglu, F, Aydogdu, S et al. The effect of tubal sterilization through electrocoagulation on the ovarian reserve. Contraception, 2009;80:90–94.Google Scholar
Hernández-Díaz, S, Werler, MM, Walker, AM et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med, 2000;343:1608–1614.CrossRefGoogle ScholarPubMed
Alonso, V, Linares, V, Bellés, M et al. Sulfasalazine induced oxidative stress: a possible mechanism of male infertility. Reprod Toxicol, 2009;27:35–40.Google Scholar
Ostensen, , Khamashta, M, Lockshin, M et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther, 2006;8:209.Google Scholar
Gutierrez, JC, Hwang, K. The toxicity of methotrexate in male fertility and paternal eratogenicity. Expert Opin Drug Metab Toxicol, 2017;1:51–58.Google Scholar
Martini, AC, Molina, RI, Tissera, AD et al. Analysis of semen from patients chronically treated with low or moderate doses of aspirin like drugs. Fertil Steril, 2003;80:221–222.CrossRefGoogle ScholarPubMed
Huang, JY, Tulandi, T, Holzer, H et al. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril, 2008;89:567–572.Google Scholar
Tao, T, del Valle, A. Human oocyte and ovarian tissue cryopreservation and its application. J Assist Reprod Genet, 2008;25:287–296.Google Scholar
Cobo, A, Kuwayama, M, Pérez, S et al. Comparison of concomitant outcome achieved with fresh and cryopreserved oocytes vitrified by the Cryotop method. Fertil Steril, 2008;89:1657–1664.Google Scholar
Chian, RC, Huang, JY, Tan, SL et al. Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod Biomed Online, 2008;16:608–610.Google Scholar
The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril, 2005;83:1622–1628.Google Scholar
Nugent, D, Meirow, D, Brook, PF et al. Transplantation in reproductive medicine: previous experience, present knowledge and future prospects. Hum Reprod Update, 1997;3:267–280.Google Scholar
Donnez, J, Dolmans, MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet, 2015;32:1167–1170.CrossRefGoogle ScholarPubMed
Van der Ven, H, Liebenthron, J, Beckmann, M et al. Ninety-five orthotropic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod, 2016;31:2031–2041.Google Scholar
Diaz-Garcia, C, Domingo, J, Garcia-Velasco, JA et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril, 2018;109:478–485.Google Scholar
Dolmans, MM, Luyckx, V, Donnez, J, Andersen, CY, Greve, T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril, 2013;99:1514–1522.Google Scholar
Shapira, M, Raanani, H, Barshack, I et al. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril, 2018;109:48–53.Google Scholar
Committee, IP, Kim, SS, Donnez, J et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet, 2012;29:465–468.Google Scholar
Robertson, JA. Ethical issues in ovarian transplantation and donation. Fertil Steril, 2000;73:443–446.Google Scholar
Blumenfeld, Z, Evron, A. Endocrine prevention of chemotherapy-induced ovarian failure. Curr Opin Obstet Gynecol, 2016;28:223–229.CrossRefGoogle ScholarPubMed
Del Mastro, L, Ceppi, M, Poggio, F et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev, 2014;40:675–683.Google Scholar
Srkalovic, G, Schally, AV, Wittliff, JL et al. Presence and characteristics of receptors for [D-Trp6] luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer. Int J Oncol, 1998;12:489–498.Google Scholar
Emous, G, Grndker, C, Ganthert, AR et al. GnRH antagonists in the treatment of gynaecological and breast cancer. Endocr Relat Cancer, 2003;10:291–299.Google Scholar
Blumenfeld, Z, Shapiro, D, Shteinberg, M et al. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus, 2000;9:401–405.Google Scholar
Gougeon, A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev, 1996;17:121–155.CrossRefGoogle ScholarPubMed
Chian, RC, Huang, JY, Gilbert, L et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril, 2009;91:2391–2398.Google Scholar
Cohen, Y, St-Onge-St-Hilaire, A, Tannus, S et al. Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes. J Assist Reprod Genet. 2018;35(9):1683–1689.Google Scholar
Buckett, WM, Chian, RC, Dean, NL et al. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril, 2008;90:546–550.Google Scholar
Bisharah, M, Tulandi, T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol, 2003;188:367–370.Google Scholar
Chen, Y, Sun, J, Zou, K et al. Treatment for lupus nephritis: an overview of systematic reviews and meta-analyses. Rheumatol Int, 2017;37:1089–1099.Google Scholar
Bernatsky, S, Clarke, A, Suissa, S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med, 2008;168:378–381.Google Scholar
Langford, C. Wegener’s granulomatosis: current and upcoming therapies. Arthritis Res Ther, 2003;5:180–191.Google Scholar
Schroeder, JO, Euler, H, Loffler, H. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med, 1987;107:344–346.Google Scholar
Manger, K, Wildt, L, Kalden, JR et al. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Autoimmun Rev, 2006;5:269–272.Google Scholar
Buyon, JP, Petri, MA, Kim, MY et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med, 2005;142:953–962.Google Scholar
Oktay, K, Hourvitz, A, Sahin, G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metabol, 2006;91:3885–3890.Google Scholar
Ahlstrom, A, Westin, C, Wikland, M et al. Prediction of live birth in frozen-thawed single blastocyst transfer cycles by pre-freeze and post-thaw morphology. Hum Reprod, 2013;28:1199–1209.Google Scholar
Goldman, RH, Racowsky, C, Farland, LV et al. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod, 2017;32:853–859.Google Scholar
Dondorp, WJ, De Wert, GM. Fertility preservation for healthy women: ethical aspects. Hum Reprod, 2009;24:1779–1785.Google Scholar
Cobo, A, Garcia-Velasco, JA, Coello, A et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril, 2016;105:755–764.e8.Google Scholar
Cobo A, García-Velasco JA, Domingo J, Pellicer A, Remohí J. Elective and Onco-fertility preservation: factors related to IVF outcomes. Hum Reprod, 2018;33(12):2222–2231.CrossRefGoogle Scholar
Somigliana, E, Ragni, G, Benedetti, F et al. Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod, 2003;18:2450–2453.Google Scholar
Carrillo, L, Seidman, D, Cittadini, E et al. The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet, 2016;33:317–323.Google Scholar
García-Velasco, JA, Somigliana, E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod, 2009;24:496–501.Google Scholar
Busacca, M, Vignali, M. Endometrioma excision and ovarian reserve: a dangerous relation. J Minim Invasive Gynecol, 2009;16:142–148.Google Scholar
Rauck, AM, Grouas, AC. Bone marrow transplantation in adolescents. Adolesc Med, 1999;10:445–449.Google Scholar
Lau, NM, Huang, JY, MacDonald, S et al. Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online, 2009;18:290–295.Google Scholar
Pienkowski, C, Menendez, M, Cartault, A et al. Turner’s syndrome and procreation. Ovarian function and Turner’s syndrome. Gynecol Obstet Fertil, 2008;36:1030–1034.Google Scholar
Sénéchal, C, Rousset-Jablonski, C. Should a systematic fertility preservation be proposed to healthy women carrying a BRCA1/2 mutation? Gynecol Obstet Fertil, 2015;43:800–805.Google Scholar
Derks-Smeets, IAP, van Tilborg, TC, van Montfoort, A et al. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD. J Assist Reprod Genet, 2017;34:1475–1482.Google Scholar
Cobo, A, Bellver, J, Domingo, J et al. New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod Biomed Online, 2008;17:68–72.Google Scholar
Bosch, E, Labarta, E, Crespo, J et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod, 2010;25:2092–2100.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×